Skip to main content
. 2015 Aug 25;10(8):e0136563. doi: 10.1371/journal.pone.0136563

Fig 3. Deferiprone down-regulates Omniscan-induced CD163+ cells in NSF skin as shown by immunohistochemistry (Panel A).

Fig 3

Immunohistochemistry staining shows deferiprone treatment decreases Omniscan-induced CD163+. The top panels (40X) show the comparative skin thickness from each group. Panel B demonstrates the quantitative analysis of the number of positively stained cells in μm2. (**p<0.01 Omniscan alone compared with control or Omniscan treated compared with deferiprone and Omniscan).